<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="brief-report" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Our Dermatol Online</journal-id>
<journal-title>Our Dermatol Online</journal-title>
<issn pub-type="epub">2081-9390</issn>
<publisher>
<publisher-name>Our Dermatology Online</publisher-name>
<publisher-loc>Poland</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">OURD-10-251</article-id>
<article-id pub-id-type="doi">10.7241/ourd.20193.5</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Brief Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Meaning of microalbuminuria during the atopic dermatitis of the child</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Loumingou</surname>
<given-names>Ida Aur&#x00E9;lie Lenga</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="corresp" rid="cor1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Loumingou</surname>
<given-names>Richard</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><italic>Department of Dermatology, University of Brazzaville Medical Center, Brazzaville, Republic of the Congo</italic></aff>
<aff id="aff2"><label>2</label><italic>Department of Nephrology, University of Brazzaville Medical Center, Brazzaville, Republic of the Congo</italic></aff>
<author-notes>
<corresp id="cor1">
<bold>Corresponding author:</bold> Dr. Ida Aur&#x00E9;lie Lenga Loumingou, E-mail: <email xlink:href="idalengaloumingou@gmail.com">idalengaloumingou@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<year>2019</year>
</pub-date>
<volume>10</volume>
<issue>3</issue>
<fpage>254</fpage>
<lpage>251</lpage>
<history>
<date date-type="received"><day>14</day><month>04</month><year>2019</year></date>
<date date-type="accepted"><day>01</day><month>05</month><year>2019</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x000a9; Our Dermatol Online 3</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
</license>
</permissions>
<abstract>
<sec id="st1">
<title>Objectives:</title>
<p>Advocate early diagnosis of vascular diseases in children with atopic dermatitis. Determine children at vascular risk during atopic dermatitis.</p>
</sec>
<sec id="st2">
<title>Method:</title>
<p>The study is transversal and analytical; performed in the University of Brazzaville Medical Center in 18 months. It focuses on children from 0 to 15 years old with atopic dermatitis. The anthropometric, clinical, and antecedent data are collected on cards as well as the balance necessarily including: fasting blood glucose, serum immunoglobulin E (IGE) and microalbuminuria.</p>
</sec>
<sec id="st3">
<title>Results:</title>
<p>80 patients were selected, 47 girls and 33 boys. The mean age was 8.9 years SD &#x00B1; 4.646. Obesity is found in 21.25&#x0025; of cases. 82, 5&#x0025; of children had hypertensive parents or diabetics in the first degree. Microalbuminuria was positive in 53.75&#x0025; of cases. It was independent of age and sex and more common in children with hyper IgE.</p>
</sec>
<sec id="st4">
<title>Conclusion:</title>
<p>The study reports arguments for a vascular predisposition and show the interest of achieving microalbuminuria in atopic dermatitis.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Atopic dermatitis</kwd>
<kwd>Arterial hypertension</kwd>
<kwd>Diabetes</kwd>
<kwd>Microalbuminuria</kwd>
<kwd>Child</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-1" sec-type="intro">
<title>INTRODUCTION</title>
<p>Atopic dermatitis (AD) is an inflammatory, pruritic and chronic condition of complex etiopathogenesis with implications for hereditary factors and environmental antigens [<xref ref-type="bibr" rid="ref1">1</xref>]. Atopic dermatitis can be considered as a systemic disease [<xref ref-type="bibr" rid="ref2">2</xref>], its clinical diagnosis is done by the criteria of the United Kingdom Working Party.</p>
<p>DA is a model of polygenic inheritance that is accompanied by stimulations of secretion of polypeptide substances and chemical mediators with vasoactive activity [<xref ref-type="bibr" rid="ref1">1</xref>]. Some metabolic manifestations such as obesity and some idiopathic nephrotic syndromes are described in AD [<xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref4">4</xref>]. The occurrence of arterial hypertension during atopic dermatitis has been suggested [<xref ref-type="bibr" rid="ref5">5</xref>].</p>
<p>The authors conducted a hospital study to look for a link between AD and common vascular pathologies such as diabetes, high blood pressure and obesity. The interest of this study is to advocate early detection and prevention of vascular diseases in children with AD.</p>
</sec>
<sec id="sec1-2" sec-type="method">
<title>PATIENTS AND METHOD</title>
<p>It is a transversal and analytical study, carried out in University of Brazzaville Medical Center in consultation from January 2015 to July 2016. The study is made by a Dermatologist and a nephrologist hospital-university.</p>
<p>Inclusion criteria were: patients aged 0-15 years with AD. Exclusion criteria were: urinary tract infection or other active infection, ongoing or long-term steroid therapy.</p>
<p>The clinical and laboratory parameters studied were: body mass index, personal and family history of diabetes, high blood pressure, asthma, ambulatory blood pressure measurement with a suitable cuff, fasting blood glucose, blood count, C reactive protein, cytobacteriological examination of urine, ADDIS count, serum immunoglobulin E (IGE), microalbuminuria.</p>
<p>Microalbuminuria was performed on urination, it was considered positive when it was greater than 20ml/g.</p>
<p>The diagnosis of AD was made thanks to the criteria of the United Kingdom Working Party. The severity of the AD was defined by the SCORAD index.</p>
<p>The information was recorded on cards. Data analysis was done by SPSS for calculating averages, standard deviations and correlations.</p>
</sec>
<sec id="sec1-3" sec-type="results">
<title>RESULTS</title>
<sec id="sec2-1">
<title>Epidemiological aspects</title>
<p>374 children were received during the study period among them, 87 had an AD (23.6&#x0025;) and 80 met the criteria of the study. There were 33 boys and 47 girls. The M/F ratio was 0.7. The average age was 8.9 years SD &#x00B1; 4.646 years. The average age of girls was 10.19 &#x00B1; 4.08 and 7.24 &#x00B1; 4.89 for boys (P = 0.099).</p>
</sec>
<sec id="sec2-2">
<title>Clinical aspects</title>
<p>There was no diabetes or ongoing hypertension in the patients.13 children were asthmatic (16.25&#x0025;), 17 obese children (21.25&#x0025;), 66 children had parents with diabetes or hypertension (82.5&#x0025;); distributed as follows: high blood pressure (n = 46), hypertension and diabetes (n = 12), diabetes (n = 8).</p>
</sec>
<sec id="sec2-3">
<title>Biological aspects</title>
<p>Microalbuminuria was positive in 43 cases (53.75&#x0025;). Mean microalbuminuria was 24.20 &#x00B1; 21.40. This average was evaluated at 27.4 &#x00B1; 28.57 for boys and 21.93 &#x00B1; 14.35 for girls (P = 0.016). 80&#x0025; of children with microalbuminuria had hypertensive or diabetic parents. IgE was elevated in 45&#x0025; of patients. The average IgE was 339.2 &#x00B1; 371.5.</p>
</sec>
<sec id="sec2-4">
<title>Correlation between microalbuminuria and the different variables studied</title>
<p>Positive microalbuminuria was found in 47.3&#x0025; of children in the 0 to 4 age group, 50&#x0025; had positive microalbuminuria in the age group of 5 to 9 years, and 60&#x0025; between 10 and 15 years old. The Pearson correlation rate is 0.022, bilateral significance 0.845 (<xref ref-type="table" rid="T1">Table 1</xref>). The averages of microalbuminuria with respect to age are shown in <xref ref-type="fig" rid="F1">Fig. 1</xref>.</p>
<table-wrap id="T1">
<label>Table 1</label>
<caption>
<p>Corrections between microalbuminuria and different variables</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-10-251-g001.tif"/>
</table-wrap>
<fig id="F1">
<label>Figure 1</label>
<caption>
<p>Microalbuminurie and age.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-10-251-g002.tif"/>
</fig>
<p>Positive microalbuminuria was found in 45&#x0025; of children who have hyper IgE. The Pearson correlation was 0.212; Bilateral significance 0.059. The microalbuminuria averages by age group are shown in <xref ref-type="fig" rid="F1">Fig. 1</xref>. There were 13 asthmatic patients among whom 5 (38.4&#x0025;) had microalbuminuria. Severe AD exist in 23.75&#x0025; cases, 73.6&#x0025; of whom had hyper IgE and positive microalbuminuria.</p>
</sec>
</sec>
<sec id="sec1-4" sec-type="discussion">
<title>DISCUSSION</title>
<p>Atopic dermatitis is an inflammatory, pruriginous and spongiotic disease [<xref ref-type="bibr" rid="ref6">6</xref>]. It is considered a systemic disease [<xref ref-type="bibr" rid="ref2">2</xref>]. prevalence of AD is high but varies by study [<xref ref-type="bibr" rid="ref7">7</xref>-<xref ref-type="bibr" rid="ref9">9</xref>]. The classic feminine predominance is found in our study [<xref ref-type="bibr" rid="ref10">10</xref>]. The penetrance of AD is variable, comorbidity is common [<xref ref-type="bibr" rid="ref11">11</xref>] other manifestations of atopy are often associated. In the study, 16.25&#x0025; of children were asthmatic, 24.7&#x0025; had AD strict.</p>
<p>The physiopathology of AD is complex [<xref ref-type="bibr" rid="ref1">1</xref>]; it is accompanied by stimulations, secretions of chemical mediators and a high cellular activity [<xref ref-type="bibr" rid="ref12">12</xref>]. These mechanisms are arguments for an alteration of the endothelial tissue. There is a relationship between inflammatory mediators and vascular and metabolic risk factors: interleukin 6 induces insulin resistance [<xref ref-type="bibr" rid="ref13">13</xref>], cytokines (TNF, IL6, interferon gamma) have a pro-inflammatory role [<xref ref-type="bibr" rid="ref14">14</xref>], T h 1, T h 2 regulatory T lymphocytes, whose activity is crucial in AD, induce atherosclerosis [<xref ref-type="bibr" rid="ref15">15</xref>], podocyte damage is found in the idiopathic nephrotic syndromes of atopic subjects [<xref ref-type="bibr" rid="ref16">16</xref>].</p>
<p>The arguments for a vascular predisposition in our study are: 82.5&#x0025; of first degree parents were diabetic and or hypertensive, the positivity of microalbuminuria in 53.75&#x0025; of children.</p>
<p>The association of AD with obesity, diabetes and arterial hypertension is gaining acceptance [<xref ref-type="bibr" rid="ref17">17</xref>,<xref ref-type="bibr" rid="ref18">18</xref>]. The link between idiopathic nephrotic syndrome and atopic dermatitis has been suggested [<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref16">16</xref>]. In our study 26.25&#x0025; of children were obese. No child was hypertensive or diabetic. For Zhang [<xref ref-type="bibr" rid="ref19">19</xref>], obesity is controversial in AD but is frequently reported in studies such as Kusunoki [<xref ref-type="bibr" rid="ref3">3</xref>] and Lim [<xref ref-type="bibr" rid="ref20">20</xref>]. The small sample in the study did not allow us to associate obesity with AD. Microalbuminuria reflects either a rise in capillary pressure or an alteration of the triple glomerular barrier or a generalized endothelial dysfunction it is a risk factor cardiovascular whose interest is established in the management of diabetes and high blood pressure [<xref ref-type="bibr" rid="ref21">21</xref>]. Positive microalbuminuria appeared to exist independently of age, more than half of the patients had positive microalbuminuria. We did not find an explanation for the peak before the age of two. The positivity of microalbuminuria appeared to be related to the elevation of immunoglobulin E and the severity of AD.</p>
</sec>
<sec id="sec1-5" sec-type="conclusion">
<title>CONCLUSION</title>
<p>The existence of pathological microalbuminuria in children with AD seems to be relevant. It seems important to systematically look for personal and familial vascular risk factors in children with AD, to ensure optimal prevention of common vascular diseases.</p>
<sec id="sec2-5">
<title>Statement of Human and Animal Rights</title>
<p>All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.</p>
</sec>
<sec id="sec2-6">
<title>Statement of Informed Consent</title>
<p>Informed consent was obtained from all patients for being included in the study.</p>
</sec>
</sec>
</body>
<back>
<ref-list>
<title>REFERENCES</title>
<ref id="ref1">
<label>1</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barbarot</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Physiopathologie de la dermatite atopique et perspectives th&#233;rapeutiques syst&#233;miques</article-title>
<source>R&#233;al Th&#233;r Dermato-V&#233;n&#233;rol</source>
<year>2016</year>
<volume>256</volume>
<fpage>1</fpage>
</nlm-citation>
</ref>
<ref id="ref2">
<label>2</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darlenski</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kazandjeva</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hristakieva</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fluhr</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>Atopic dermatitis as a systemic disease</article-title>
<source>Clin Dermatol</source>
<year>2014</year>
<volume>32</volume>
<fpage>409</fpage>
<lpage>13</lpage>
</nlm-citation>
</ref>
<ref id="ref3">
<label>3</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kusunoki</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Obesity and atopic dermatitis, allergic rhinitis</article-title>
<source>Arerugi</source>
<year>2017</year>
<volume>66</volume>
<fpage>984</fpage>
<lpage>9</lpage>
</nlm-citation>
</ref>
<ref id="ref4">
<label>4</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Audard</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sahali</surname>
<given-names>DIL</given-names>
</name>
</person-group>
<article-title>Pathog&#233;nie du syndrome n&#233;phrotique &#224;l&#233;sions glom&#233;rulaires minimes</article-title>
<source>Med Sci (Paris)</source>
<year>2008</year>
<volume>24</volume>
<fpage>853</fpage>
<lpage>8</lpage>
</nlm-citation>
</ref>
<ref id="ref5">
<label>5</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silverberg</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kwasny</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Menter</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kordoro</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Paller</surname>
<given-names>AS</given-names>
</name>
</person-group>
<article-title>Central obesity and high blood pressure in pediatric patient with atopic dermatitis</article-title>
<source>J Am Acad Dermatol</source>
<year>2015</year>
<volume>151</volume>
<fpage>144</fpage>
<lpage>52</lpage>
</nlm-citation>
</ref>
<ref id="ref6">
<label>6</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Misery</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Atopic dermatidis: new trends and persoectives</article-title>
<source>Clin Rev Allerg Immunol</source>
<year>2011</year>
<volume>41</volume>
<fpage>296</fpage>
<lpage>7</lpage>
</nlm-citation>
</ref>
<ref id="ref7">
<label>7</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baghoud</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Pr&#233;valence et profil clinique de la Dermatite atopique en Alg&#233;rie</article-title>
<source>Ann Dermatol V&#233;n&#233;rol</source>
<year>2012</year>
<volume>9</volume>
<fpage>13140</fpage>
</nlm-citation>
</ref>
<ref id="ref8">
<label>8</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kay</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gawkrodger</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Mortimer</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Jaron</surname>
<given-names>AG</given-names>
</name>
</person-group>
<article-title>The prevalence of childhood atopic eczema in a general population</article-title>
<source>J Am Acad Dermatol</source>
<year>1994</year>
<volume>30</volume>
<fpage>35</fpage>
<lpage>9</lpage>
</nlm-citation>
</ref>
<ref id="ref9">
<label>9</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chai</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>
<article-title>Prevalence of childhood atopic dermatitis an urban and rural community-based study in Shanghai, China</article-title>
<source>PLOS One</source>
<year>2012</year>
<volume>7</volume>
<fpage>e36174</fpage>
</nlm-citation>
</ref>
<ref id="ref10">
<label>10</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Charpin</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Vervloet</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Pr&#233;sentation g&#233;n&#233;rale de l&#x0027;&#233;tude ISAAC</article-title>
<source>Rev Fran&#231;d&#x0027;Allergol d&#x0027;Immunol Clin</source>
<year>1998</year>
<volume>38</volume>
<fpage>375</fpage>
<lpage>382</lpage>
</nlm-citation>
</ref>
<ref id="ref11">
<label>11</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davis</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Practice gaps. Pediatric atopic dermatitis and associated morbidities</article-title>
<source>J Am Acad Dermatol</source>
<year>2015</year>
<volume>151</volume>
<fpage>152</fpage>
<lpage>3</lpage>
</nlm-citation>
</ref>
<ref id="ref12">
<label>12</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gittler</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Shemer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Suarez Farinas</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fuentes-Duculan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gulewicz</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>CQ</given-names>
</name>
<etal/>
</person-group>
<article-title>Progressive activation of Th2 Th22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis</article-title>
<source>J Allergy Clin Immunol</source>
<year>2012</year>
<volume>130</volume>
<fpage>1344</fpage>
<lpage>54</lpage>
</nlm-citation>
</ref>
<ref id="ref13">
<label>13</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bastard</surname>
<given-names>J P</given-names>
</name>
<name>
<surname>Feve</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Insulino r&#233;sistance et Diab&#232;te: Quel r&#244;le jouent les interleukines</article-title>
<source>STV</source>
<year>2009</year>
<volume>21</volume>
<fpage>307</fpage>
<lpage>14</lpage>
</nlm-citation>
</ref>
<ref id="ref14">
<label>14</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ait</surname>
<given-names>oufella H</given-names>
</name>
<name>
<surname>Tedgui</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mallat</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>L&#x0027;ath&#233;roscl&#233;rose: une maladie inflammatoire</article-title>
<source>STV</source>
<year>2008</year>
<volume>20</volume>
<fpage>25</fpage>
<lpage>33</lpage>
</nlm-citation>
</ref>
<ref id="ref15">
<label>15</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robertson</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Hansson</surname>
<given-names>GK</given-names>
</name>
</person-group>
<article-title>T cells in artherogenesis: for better or worse</article-title>
<source>Aterioscler Thromb Vasc Biol</source>
<year>2006</year>
<volume>26</volume>
<fpage>2421</fpage>
<lpage>32</lpage>
</nlm-citation>
</ref>
<ref id="ref16">
<label>16</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Sung</surname>
<given-names>FC</given-names>
</name>
</person-group>
<article-title>Occurrence of common allergic diseases in children with idiopathic nephrotic syndrome</article-title>
<source>J Epidemiol</source>
<year>2015</year>
<volume>25</volume>
<fpage>370</fpage>
<lpage>7</lpage>
</nlm-citation>
</ref>
<ref id="ref17">
<label>17</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thyssen</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Halling-Overgaard</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>YMF</given-names>
</name>
<name>
<surname>Gislason</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Skov</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Egerberg</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The association between cardiovascular disease and type 2 diabetes in adults with atopic dermatitis: a systematic review and meta-analysis</article-title>
<source>J Dermatol</source>
<year>2018</year>
<volume>178</volume>
<fpage>879</fpage>
<lpage>88</lpage>
</nlm-citation>
</ref>
<ref id="ref18">
<label>18</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andersen</surname>
<given-names>YMF</given-names>
</name>
<name>
<surname>Egeberg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hamann</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Skov</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gislason</surname>
<given-names>GH</given-names>
</name>
<name>
<surname>Skaaby</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Linneberg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Thyssen</surname>
<given-names>JP</given-names>
</name>
</person-group>
<article-title>Poor agreement in questionnaire-based diagnostic criteria for adult atopic dermatitis is a challenge when examining cardiovascular comorbidity</article-title>
<source>Allergy</source>
<year>2018</year>
<volume>73</volume>
<fpage>923</fpage>
<lpage>31</lpage>
</nlm-citation>
</ref>
<ref id="ref19">
<label>19</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Silverberg</surname>
<given-names>JI</given-names>
</name>
</person-group>
<article-title>Association of atopic dermatitis with bering overweight and obese: a systematic review and meta analysis</article-title>
<source>J Am Acad Dermatol</source>
<year>2015</year>
<volume>72</volume>
<fpage>606</fpage>
<lpage>16</lpage>
</nlm-citation>
</ref>
<ref id="ref20">
<label>20</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Sim</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>HG</given-names>
</name>
</person-group>
<article-title>Physical Activity, Sedentary Habits, Sleep, and Obesity are Associated with Asthma, Allergic Rhinitis, and Atopic Dermatitis in Korean Adolescents</article-title>
<source>Yonsei Med J</source>
<year>2017</year>
<volume>58</volume>
<fpage>1040</fpage>
<lpage>6</lpage>
</nlm-citation>
</ref>
<ref id="ref21">
<label>21</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sizinger</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kritz</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>La microalbuminurie est elle un facteur de risque en pathologie vasculaire</article-title>
<source>Sang Thromb Vaiss</source>
<year>1995</year>
<volume>7</volume>
<fpage>613</fpage>
<lpage>8</lpage>
</nlm-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="supported-by">
<p><bold>Source of Support:</bold> Nil</p>
</fn>
<fn fn-type="conflict">
<p><bold>Conflict of Interest:</bold> None declared.</p>
</fn>
</fn-group>
</back>
</article>
